StonvexLoading…
StonvexStonvexStonvexCore line items from VEEV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $3.20B | $2.75B | $2.36B | $2.16B |
Operating Income | $916.37M | $691.43M | $429.33M | $459.09M |
Net Income | $908.91M | $714.14M | $525.71M | $487.71M |
EPS (Diluted) | $5.44 | $4.32 | $3.22 | $3.00 |
Total Assets | $8.98B | $7.34B | $5.91B | $4.80B |
Total Liabilities | $1.76B | $1.51B | $1.27B | $1.09B |
Cash & Equivalents | $1.42B | $1.12B | $703.49M | $886.47M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 163.78M | 162.58M | 161.26M | 162.44M |